To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts.
On Rare Disease Day 2024, we hear from Chris Moore, President, Veeva Europe who explores how companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster.
